Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00670020
Other study ID # 18821
Secondary ID
Status Completed
Phase N/A
First received April 29, 2008
Last updated April 30, 2008
Start date January 2001
Est. completion date December 2006

Study information

Verified date April 2008
Source University of Washington
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether supplemental perioperative oxygen significantly decreases the incidence of post-Cesarean endometritis and wound infection among women who undergo Cesarean section after the onset of labor.


Description:

Women undergoing cesarean section after rupture of membranes or onset of labor are randomized in a one to one ratio to either normal or supplemental perioperative oxygen during cesarean section and for two hours afterwards.


Recruitment information / eligibility

Status Completed
Enrollment 143
Est. completion date December 2006
Est. primary completion date December 2006
Accepts healthy volunteers No
Gender Female
Age group 16 Years and older
Eligibility Inclusion Criteria:

- Women who underwent a clinically indicated cesarean delivery after the onset of labor or rupture of membranes

Exclusion Criteria:

- Cesarean delivery prior to the onset of labor or rupture of membranes

- emergent cesarean delivery

- general endotracheal anesthesia

- clinical chorioamnionitis

- HIV infection

- less than 16 years of age

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
supplemental perioperative oxygen
increased perioperative oxygen verses non-interventional oxygen

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Washington

Outcome

Type Measure Description Time frame Safety issue
Primary surgical site infection within two weeks of cesarean section No